[{"status": "Terminated", "city": "Sugar Land", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77634", "recalling_firm": "PharMedium Services, Llc", "address_1": "12620 W Airport Blvd Ste 130", "address_2": "N/A", "postal_code": "77478-6200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0985-2017", "product_description": "Succinylcholine Chloride Injection (Preserved) 20 mg per mL, 200 mg per 10 mL, 10 mL Total Volume in BD Syringe, For IV Use, PharMedium Services, LLC, Cleveland, MS --- NDC 61553-364-65", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; media fill failure at manufacturer", "recall_initiation_date": "20170626", "center_classification_date": "20170714", "termination_date": "20200429", "report_date": "20170726", "code_info": "Lots: 171390026D Exp. 08/20/2017; 171370064D Exp. 8/16/2017; 171390027D Exp. 8/20/2017; 171420074D Exp. 8/21/2017; 171430062D Exp. 8/22/2017; 171440058D Exp. 8/23/2017; 171450001D Exp. 8/23/2017; 171450002D Exp. 8/23/2017; 171450056D Exp. 08/24/2017"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0094-2015", "product_description": "Hydroxyzine hydrochloride 25 mg/mL injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "10 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 08192014@51, Exp 11/17/2014", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "7 units", "code_info": "Rx 29183 Exp, 5/21/2014", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Pfizerpen (penicillin G) 24 MU/300 mL 0.9%NS, Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29183, Discard After 05/21/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1455-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79367", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd Nw", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0914-2018", "product_description": "RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10", "product_quantity": "17,192 cartons (1,719,200 tablets)", "reason_for_recall": "Failed Stability Specifications", "recall_initiation_date": "20180226", "center_classification_date": "20180709", "termination_date": "20200915", "report_date": "20180314", "code_info": "Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018"}, {"status": "Terminated", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76383", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-0479-2017", "product_description": "Mimvey Lo (estradiol and norethindrone acetate tablets USP), 0.5 mg/0.1 mg, 28 tablets per blister card (NDC 0093-5454-18), packaged in 3 blister cards per carton (NDC 0093-5454-62), Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA  18960.", "product_quantity": "17,473 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: out of  specification test results for the norethindrone impurity.", "recall_initiation_date": "20170202", "center_classification_date": "20170216", "termination_date": "20180206", "report_date": "20170222", "code_info": "Lot # 33809881A, Exp 05/17; 33811151A, Exp 08/17", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as    PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD22845_1, EXP: 4/30/2014;  LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD73525_49, EXP: 5/30/2014.", "address_2": "", "product_quantity": "420 Tablets", "code_info": "METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes    Pedigree: AD21790_67, EXP: 5/1/2014;  Pedigree: AD73525_52, EXP: 5/30/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 63304057901", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-678-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0859-2021", "product_description": "Occular Allergy Blend 87% Alcohol; In Equal Parts of Apis Mellifica 7x Allium Cepa 7x Euphrasia Officinalis 7X Sabadilla 7X, WHP Homeopathic Medicine For Manufacturing Only, 500 ml. Manufcatured by Washington Homeopathic Products 260JR Hawvermale Way, Berkeley Springs WV 25411", "product_quantity": "2/500 mL bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 30148"}, {"status": "Terminated", "city": "Sellersville", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65826", "recalling_firm": "Teva Pharmaceuticals USA, Inc.", "address_1": "650 Cathill Rd", "address_2": "N/A", "postal_code": "18960-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-842-2013", "product_description": "Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-4339-01", "product_quantity": "6267 bottles", "reason_for_recall": "Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules", "recall_initiation_date": "20130723", "center_classification_date": "20130806", "termination_date": "20140827", "report_date": "20130814", "code_info": "Lot # N07321, Exp 6/14"}, {"status": "Ongoing", "city": "East Durham", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97382", "recalling_firm": "Haleon US Holdings LLC", "address_1": "3169 Route 145", "address_2": "N/A", "postal_code": "12423-1416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0592-2025", "product_description": "Sensodyne PRONAMEL (Potassium nitrate 5%, Sodium fluoride 0.25%) Active SHIELD Toothpaste for Sensitive Teeth, Fresh Mint, Net WT 3.4OZ (96.4g) Tube, 6 tubes x 2 inners, per case, Distributed by GSK Consumer Healthcare, Warren, NJ 07059. UPC 3 10158 35691 2", "product_quantity": "46,692 tubes", "reason_for_recall": "Labeling: Label Mix-up: The outer carton is labelled Fresh Mint. The tube is labelled Cool Mint/Whitening. The toothpaste inside the tube is Fresh Mint as indicated on the outer carton", "recall_initiation_date": "20250805", "center_classification_date": "20250819", "report_date": "20250827", "code_info": "Lot # for Case: 5058RB, Exp. date: 08/31/2027 Lot # for Carton and Tube: NJ2A, Exp 08/31/2027"}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80828", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-1130-2018", "product_description": "Valsartan Tablets, USP 40 mg Rx Only NDC 50268-783-15 50 Tablets (5x10) Unit Dose Manufactured for: AvKARE, Inc. Pulaski, TN 38478", "product_quantity": "6776 cartons (338,800 tablets)", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180814", "center_classification_date": "20180828", "termination_date": "20200507", "report_date": "20180905", "code_info": "Lots: 18491 Exp. 10/2018; 19531 Exp. 04/2019; 20168 Exp. 05/2019; 20671 Exp. 08/2019; 21049 Exp. 10/2019; 21635 Exp. 10/2019"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.", "address_2": "Suite 180", "product_quantity": "58  x 30 ml Vials", "code_info": "Lot: 20121126-H", "center_classification_date": "20130515", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Cyanocobalamin 1000 mcg/ml, injection 30 mL, MDV, For Office Use Only, Green Valley Drugs,       Manufactured by Green Valley Drugs, Henderson, NV.", "report_date": "20130522", "classification": "Class I", "openfda": {}, "recalling_firm": "Green Valley Drugs", "recall_number": "D-322-2013", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "63953", "termination_date": "20130517", "more_code_info": "", "recall_initiation_date": "20121204", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "3 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Pyridoxine B6 100mg Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0446-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88850", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0280-2022", "product_description": "Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310,  NDC 52565-009-50", "product_quantity": "52,104 glass bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20211012", "center_classification_date": "20211213", "termination_date": "20240618", "report_date": "20211222", "code_info": "Lot #: 13262, Exp. 03/2022; 14217, Exp. 08/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "71201", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1086-2015", "product_description": "Daytrana (methylphenidate transdermal system), Delivers 30 mg over 9 hours (3.3mg/hr), CII, 30 patches per box, Manufactured for Noven Therapeutics LLC, Miami, FL 33186, by Noven Pharmaceuticals Inc., Miami, FL 33186, NDC # 68968-5555-3", "product_quantity": "125,340 Patches", "reason_for_recall": "Defective Delivery System: One lot exceeded the mechanical peel specification", "recall_initiation_date": "20150112", "center_classification_date": "20150528", "termination_date": "20190319", "report_date": "20150603", "code_info": "Lot # 73346, Exp 03/2015", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0562-2017", "product_description": "LP CREAM (Lidocaine 15%/Prilocaine 5%), Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76472", "recalling_firm": "Synergy Rx", "address_1": "4901 Morena Blvd Ste 504A", "address_2": "N/A", "postal_code": "92117-7310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0599-2017", "product_description": "CUSTOM LIGHTENING/BRIGHTENING CREAM, Rx only, Synergy RX, 4901 Morena Blvd # 504-A San Diego, CA 92117 (855) 792-6676", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: There are also CGMP Deviations.", "recall_initiation_date": "20170210", "center_classification_date": "20170315", "termination_date": "20170523", "report_date": "20170322", "code_info": "All Lots"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-529-2013", "product_description": "Poly Hist Forte, Nasal Decongestant, Antihistamine,  100 count bottle, OTC, Manufactured for: Poly Pharmaceuticals, Quitman, MS 39355 NDC 50991-210-01", "product_quantity": "330158 Bulk tablets.", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 12L005  Exp 10/14."}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1154-2019", "product_description": "HCG 4,100 Units/vial Injection, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "1 vial", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 60"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-330"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["313391", "1724481"], "spl_id": ["1eed1f06-6d04-4057-87ed-782c6850e7d2"], "spl_set_id": ["f347f490-7199-4de6-bca2-0d44a74979af"], "package_ndc": ["42192-330-30", "42192-330-01", "42192-330-10"], "is_original_packager": [true], "upc": ["0342192330108"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "85721", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the US and Puerto Rico", "recall_number": "D-1299-2020", "product_description": "NP Thyroid 60, Thyroid Tablets, USP, 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC, Alpharetta, GA  30005, NDC 42192-330-01.", "product_quantity": "29,304 bottles", "reason_for_recall": "Superpotent Drug.", "recall_initiation_date": "20200522", "center_classification_date": "20200608", "termination_date": "20220119", "report_date": "20200610", "code_info": "Lots: M330J18-2A,  M330J18-3 Exp. AUG-2020"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Nitroglycerin all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0833-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Seymour", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71656", "recalling_firm": "Kremers Urban Pharmaceuticals, Inc.", "address_1": "1101 C Ave W", "address_2": "N/A", "postal_code": "47274-3342", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1237-2015", "product_description": "Nitroglycerin Transdermal System 0.4 mg/hr (18 cm2), For Transdermal Use Only, 30 Systems (patches) per box, Rx Only,  Manufactured for: Kremers Urban Pharmaceuticals Inc., Princeton, NJ, 08540, USA, By LTS Lohmann Therapie Systeme AG, Anderach, Federal Republic of Germany, NDC 62175-124-01", "product_quantity": "16,504 Boxes", "reason_for_recall": "Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.", "recall_initiation_date": "20150707", "center_classification_date": "20150714", "termination_date": "20160212", "report_date": "20150722", "code_info": "Lot #: 5267504, Exp 07/2015", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0270-2017", "product_description": "Lipotropic (L-Carnitine 170 mg + Methylcobalamin 300 mcg + Thiamine HCL 20 mg + Riboflavin-5-phosphate Sod 2 mg + Niacinamide 20 mg + Pyridoxine HCL 2 mg + Folic Acid 1 mg/Lidocaine HCL 10 mg/ml), (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "987 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.     Known lot codes (Exp Date): 09022016A (12/31/2016), 07282016C (12/31/2016)"}, {"status": "Terminated", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86171", "recalling_firm": "Eosera, Inc.", "address_1": "5000 South Fwy Ste 106", "address_2": "N/A", "postal_code": "76115-3902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1500-2020", "product_description": "Ear Itch MD Anti-Itch Spray (pramoxine HCL 1%) 0.5 FL OZ (15 mL) bottles, Eosera, Inc. 5000 South Freeway Fort Worth, TX 76115, NDC 72429-0071-5, UPC 851722007125", "product_quantity": "43,424 bottles", "reason_for_recall": "cGMP Deviations.", "recall_initiation_date": "20200804", "center_classification_date": "20200813", "termination_date": "20210910", "report_date": "20200819", "code_info": "Lot #: F203071 Exp. SEP 21; F203059 Exp. OCT 21; F193095, F193094 Exp. MAY 21; F193093 Exp. APR 21; F193082 Exp. MAR 21; F193069 Exp. FEB 21; F193061 Exp. JAN 21; F193058, F193054 Exp. DEC 20; F193032,  F193030, F193029, F193028, F193027, F193026, F193025, F193024 Exp. AUG 20"}, {"status": "Ongoing", "city": "Deer Park", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["CHLORPHENIRAMINE MALEATE 4MG"], "generic_name": ["CHLORPHENIRAMINE MALEATE 4MG"], "manufacturer_name": ["Athlete's Needs, Inc."], "product_ndc": ["53185-277"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPHENIRAMINE MALEATE"], "rxcui": ["1363309"], "spl_id": ["3bbe161c-4342-40b5-82b6-5270ef0e31d3"], "spl_set_id": ["4d974959-25fc-4707-9b72-9afbf47b76f1"], "package_ndc": ["53185-277-24"], "is_original_packager": [true], "upc": ["0092617099706"], "unii": ["V1Q0O9OJ9Z"]}, "product_type": "Drugs", "event_id": "95590", "recalling_firm": "BLI International, Inc.", "address_1": "75 N Industry Ct", "address_2": "N/A", "postal_code": "11729-4601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was shipped to two private label customers ( OH & MO) as a final packaged product.", "recall_number": "D-0029-2025", "product_description": "Chlorpheniramine Maleate 4 mg tablets, 24-count bottle, Manufactured For: Athlete's Needs, Novi, MI 48377, NDC 53185-277-24", "product_quantity": "4,901 cases/24 count each case", "reason_for_recall": "Superpotent Drug: Stability failure for assay at 6 months test time-point.", "recall_initiation_date": "20241021", "center_classification_date": "20241030", "report_date": "20241106", "code_info": "Lot # 24A27724, Exp 01/31/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Toms River", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67810", "recalling_firm": "Pure Edge Nutrition", "address_1": "1182 Fischer Blvd Ste 3", "address_2": "N/A", "postal_code": "08753-3093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1368-2014", "product_description": "Bella Vi eXtreme ACCELERATOR Dietary Supplement Capsules, 30 count bottles, www.BellaViProducts.com, distributed by Pure Edge Nutrition, LLC, Toms River, NJ", "product_quantity": "unknown", "reason_for_recall": "Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein", "recall_initiation_date": "20131010", "center_classification_date": "20140612", "termination_date": "20161007", "report_date": "20140618", "code_info": "lot # BTRX7654 EXP: 2015/07/08"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0100-2016", "product_description": "HYDROXYPROGESTERONE CAPROATE OIL, injectable Solution, 250 mg/mL, syringe sizes: 4 mL; 5 mL; 6 mL; 10 mL; 16 mL; 18 mL; 20 mL; and 22 mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "3 (4mL) syringes, 4 (5mL) syringes, 1 (6mL) syringe, 13 (10mL) syringes, 1 (16mL) syringe, 1 (18mL) syringe, 14 (20mL) syringes, 2 (22mL) syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12182014@7, t12052014@12, t10312014@21, t10102014@21, t10072014@6, t09172014@30, t09152014@11, t08132014@13, t08112014@28, t07282014@28, t07282014@16, t07012015@7, t06302015@31, t06222015@17, t06112015@14, t06022015@17, t05182015@24, t05152015@19, t05072015@9, t04272015@19, t04232015@22, t04212015@16, t04162015@21, t04092015@2, t04022015@27, t03162015@16, t03052015@25, t03022015@13, t02272015@22, t02202015@23, t02172015@8, t02132015@19, 08202014@12, 05042015@11; t02062015@29, t03312015@5, t06052015@3, t06172015@47, t06292015@13, and t10232014@22, t07242014@6"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0345-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0160-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220418, Exp. 10/2023; 220560, Exp. 11/2023."}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0843-2021", "product_description": "Neutrogena Invisible Daily defense body spray sunscreen BROAD SPECTRUM SPF 60+, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), NET WT. 5.0 OZ. (141 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 11154 2", "product_quantity": "88,380 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Englewood", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82704", "recalling_firm": "Stiff Boy LLC", "address_1": "90 Highwood Ave", "address_2": "N/A", "postal_code": "07631-1717", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1321-2019", "product_description": "The Beast, The Beast can be taken under the situation of Heart disease and even after drinking, 4600 mg X 4 Capsules per packet.", "product_quantity": "1000 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.", "recall_initiation_date": "20190506", "center_classification_date": "20190605", "termination_date": "20250916", "report_date": "20190605", "code_info": "All lots"}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-442-2013", "product_description": "Lloyd Thyro-Tab 0.150 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "9,575,108 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HE27811, HD27811, Exp Apr-13; HC00512, Exp Jul-13; HD04112, HE06212, Exp Sep-13."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA070583"], "brand_name": ["BUPIVACAINE HYDROCHLORIDE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1159", "0409-1160", "0409-1162", "0409-1163", "0409-1165", "0409-9043", "0409-9046", "0409-9045", "0409-9042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012384", "1012396", "1012404", "1672917", "1672919", "1724786", "1724787", "1724880", "1724884", "1725078", "1725082", "1867594", "1867596"], "spl_id": ["3c6a5b9f-4ea0-4ccd-a384-a90e4ad379e7"], "spl_set_id": ["02a845c3-4521-4926-e397-25ab536e7cf6"], "package_ndc": ["0409-1159-18", "0409-1159-01", "0409-1159-19", "0409-1159-02", "0409-1160-18", "0409-1160-01", "0409-1162-18", "0409-1162-01", "0409-1162-19", "0409-1162-02", "0409-1163-18", "0409-1163-01", "0409-1165-18", "0409-1165-01", "0409-1165-19", "0409-1165-02", "0409-9043-11", "0409-9043-01", "0409-9046-11", "0409-9046-01", "0409-9045-11", "0409-9045-01", "0409-9045-16", "0409-9045-17", "0409-9042-11", "0409-9042-01", "0409-9042-16", "0409-9042-17"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "66260", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-380-2014", "product_description": "0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-02", "product_quantity": "118,100 vials", "reason_for_recall": "Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.", "recall_initiation_date": "20130712", "center_classification_date": "20131218", "termination_date": "20150203", "report_date": "20131225", "code_info": "Lot # 18-136-DK; Exp. 6/14"}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022185"], "brand_name": ["TACLONEX"], "generic_name": ["CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE"], "manufacturer_name": ["LEO Pharma Inc."], "product_ndc": ["50222-501"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["BETAMETHASONE DIPROPIONATE", "CALCIPOTRIENE HYDRATE"], "rxcui": ["833461", "833463"], "spl_id": ["5d56e57e-6b91-4916-96d8-6dca1af7487d"], "spl_set_id": ["757c914f-dd8d-43cc-a973-212d591af4af"], "package_ndc": ["50222-501-51", "50222-501-06", "50222-501-66"], "is_original_packager": [true], "unii": ["826Y60901U", "S7499TYY6G"]}, "product_type": "Drugs", "event_id": "76370", "recalling_firm": "LEO PHARMA INC", "address_1": "7 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within US", "recall_number": "D-0477-2017", "product_description": "Taclonex (calcipotriene and betamethasone dipropionate)  Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and  (b)120 g (50222-501-66)  tubes,  Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054.", "product_quantity": "189,610 units", "reason_for_recall": "Labeling: Incorrect or missing package insert:  the affected product was packaged with an out-of-date package insert (PI) dated February 2014.", "recall_initiation_date": "20170116", "center_classification_date": "20170215", "termination_date": "20171212", "report_date": "20170222", "code_info": "Lot #: (a):  EK9025,  Exp. 2/28/2017; EL1057, Exp. 3/31/2017; EL4637, Exp. 6/30/2017;  EM0825B, Exp. 11/30/2017; EM3992, Exp. 1/31/2019; A22902, Exp. 5/31/2019; A31838, Exp. 9/30/2019  Lot #:EK7007A, EK7007AA,  Exp. 1/31/2017; EL2024, EL2979, Exp. 5/31/2017; EL8069, Exp. 10/31/2017; EA20780AA,  Exp. 5/31/2019.", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["CAREONE SEVERE CONGESTION NASAL"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["American Sales Company"], "product_ndc": ["41520-108"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["978439ab-6968-4f1b-a2b0-4247f11e265a"], "spl_set_id": ["d1dba68b-c4e1-4afc-9aee-6a51341b89f5"], "package_ndc": ["41520-108-10"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0607-2022", "product_description": "Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,  DISTRIBUTED BY FOODHOLD U.S.A., LLC, LANDOVER, MD 20785. NDC 41520-108-10", "product_quantity": "3,192 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0716; Exp 12/31/2022); 1FK1251, Exp 02/28/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Baudette", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89556", "recalling_firm": "ANI Pharmaceuticals, Inc.", "address_1": "210 W Main St", "address_2": "N/A", "postal_code": "56623-2467", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0565-2022", "product_description": "Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977", "product_quantity": "205,662 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20220215", "center_classification_date": "20220217", "termination_date": "20221025", "report_date": "20220223", "code_info": "Lot #: a) 19B029A, Exp. Date 02/2022; 19D021A, Exp. Date 04/2022.  b) 19A087B, 19A088B, 19A089B, 19A090B, Exp. Date 02/2022; 19A086B, 19A091B, 19B019B, Exp. Date 02/2022.  c) 19B020C, 19B021C, 19B027C, 19B028C, Exp. Date 02/2022, 19E056C, 19E057C, Exp. Date 05/2022;  19E059C, Exp. Date 06/2022  19G072C, Exp. Date 07/2022"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077200"], "brand_name": ["ZADITOR"], "generic_name": ["KETOTIFEN FUMARATE"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-4011"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["KETOTIFEN FUMARATE"], "rxcui": ["284380", "311237"], "spl_id": ["bed738a0-2943-46e7-a65e-2440dac7971b"], "spl_set_id": ["ac66b1e4-c2b0-a4c3-09e3-ebd44a2f7c9f"], "package_ndc": ["0065-4011-05", "0065-4011-06", "0065-4011-11", "0065401105"], "is_original_packager": [true], "upc": ["0300654011057"], "unii": ["HBD503WORO"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1317-2022", "product_description": "Systane Zaditor, ketotifen fumarate ophthalmic solution 0.035%, Antihistamine eye drops, Eye Itch Relief, up to 12 Hours, Sterile, 30 day supply, 5mL (0.17 FL OZ) bottle per box, Alcon, NDC 0065-4011-05.", "product_quantity": "9 boxes", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "Part# 0065401105", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml", "code_info": "All lots distributed between November 2014 and May 2015;  04272015@27, 6/26/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Hydromorphone 80 mg/ml + Fentanyl 15,000 mcg/ml + Bupivacaine 30 mg/ml + Baclofen 750 mcg/ml Intrathecal Solution, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1732-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "North Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021606"], "brand_name": ["ZEMPLAR"], "generic_name": ["PARICALCITOL"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-9036", "0074-4314", "0074-4317", "0074-9037"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PARICALCITOL"], "rxcui": ["577315", "577317", "606854", "606859"], "spl_id": ["ed8862d9-4037-4a30-9be6-42f2613c34cd"], "spl_set_id": ["1b27c026-2d60-47b4-2a9c-ded1818f21b5"], "package_ndc": ["0074-4314-30", "0074-4317-30", "0074-4317-73", "0074-9036-30", "0074-9037-30"], "is_original_packager": [true], "upc": ["0300749036309", "0300749037306"], "nui": ["M0007651", "N0000175907", "N0000175849"], "pharm_class_cs": ["Ergocalciferols [CS]"], "pharm_class_epc": ["Vitamin D2 Analog [EPC]", "Vitamin D Analog [EPC]"], "unii": ["6702D36OG5"]}, "product_type": "Drugs", "event_id": "73611", "recalling_firm": "AbbVie Inc.", "address_1": "1 N Waukegan Rd", "address_2": "N/A", "postal_code": "60064-1802", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0833-2016", "product_description": "Zemplar (paricalcitol) capsules, 1 mcg, 30-count bottle, Rx Only, Mfd for AbbVie Inc. North Chicago, IL 60064, NDC 0074-4317-30.", "product_quantity": "307 bottles", "reason_for_recall": "Failed Content Uniformity Specifications", "recall_initiation_date": "20160324", "center_classification_date": "20160421", "termination_date": "20161020", "report_date": "20160427", "code_info": "Lot #1055586, Exp.1/21/ 2018"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80463", "recalling_firm": "MAJOR PHARMACEUTICALS", "address_1": "17177 N Laurel Park Dr", "address_2": "N/A", "postal_code": "48152-2693", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0980-2018", "product_description": "Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10) Unit Dose per carton, Rx only, Manufactured by: Wockhardt Limited, H-14/2, M.I.D.C. Area, Waluj, Aurangabad, Maharashtra, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ  07054; Distributed by: MAJOR Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI  48152; NDC 0904-5502-61.", "product_quantity": "5,933 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.", "recall_initiation_date": "20180626", "center_classification_date": "20180724", "termination_date": "20190410", "report_date": "20180801", "code_info": "Lot #: T-01082, Exp 08/18; DR10445A, Exp 09/18; DR10443A, Exp 12/18; DR10445B, Exp 03/19; DR10725A, Exp 07/19; DS10024A, DS10040A, Exp 10/19."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "I5406 Exp 9/30/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Dexpanthenol 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-720-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1371-2019", "product_description": "Nasal Decongestant Liquid, Pseudoephedrine HCl, 30 mg in each teaspoonful, 4 Fl. oz. (118 mL) bottle, NDC:0536-1850-97, Distributed by Rugby Laboratories, Livonia MI 48152.", "product_quantity": "62,748 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: 17G002, Exp. 07/2019; 17H024, Exp. 08/2019; 17M023, Exp. 12/2019; 18F012, Exp. 06/2020."}, {"status": "Ongoing", "city": "South Plainfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89503", "recalling_firm": "AMS Packaging Inc", "address_1": "161 Helen St", "address_2": "", "postal_code": "07080-3806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0647-2022", "product_description": "Premium Nature Instant Hand Sanitizer, (ethyl alcohol 70%), plastic bottle packaged as (a) 8 OZ, UPC 8 19192 02866 8; (b) 16 OZ, UPC 8 19192 02874 3;  Premium Nature, South Plainfield, NJ.", "product_quantity": "487,000 bottles", "reason_for_recall": "Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.", "recall_initiation_date": "20220128", "center_classification_date": "20220307", "report_date": "20220302", "code_info": "All lots within expiry and labelled as 'Made in the USA'", "more_code_info": ""}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0471-2019", "product_description": "Zinc Sulfate, 5mg/mL injection, 10ml vial, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684", "product_quantity": "2 10 ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 11132018@9 BUD: 12/28/2018;"}, {"status": "Terminated", "city": "Little Rock", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72028", "recalling_firm": "Cantrell Drug Company", "address_1": "7321 Cantrell Rd", "address_2": "N/A", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1160-2016", "product_description": "HEPARIN Sodium in 0.45% Sodium Chloride, 1 USP Unit/2 mL (0.5 USP Units/mL), Rx Only, Cantrell Drug Co., Little Rock, AR --- NDC 52533-148-16, UPC: 0100352533148163", "product_quantity": "4170 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry", "recall_initiation_date": "20150821", "center_classification_date": "20160706", "termination_date": "20170203", "report_date": "20160713", "code_info": "Lot: 6146, exp 9/5/15"}, {"status": "Terminated", "city": "Grand Rapids", "state": "MI", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80893", "recalling_firm": "Hellolife", "address_1": "4460 44th St SE Ste C600", "address_2": "N/A", "postal_code": "49512-4150", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Algeria  Australia  Belgium  Brazil  Bulgaria  Canada  Colombia  Croatia  Cyprus  Czech Republic  Denmark  Dominican Republic  Ecuador  Estonia  French Polynesia  Greece  Guadeloupe  Guam  Hong Kong  Hungary  India  Ireland  Israel  Italy  Latvia  Lithuania  Martinique  Mexico  Monaco  Netherlands  New Zealand  Norway  Peru  Poland  Portugal  Romania  Russia  Russian Federation  Saudi Arabia  Senegal  Serbia  Slovakia  Slovakia (Slovak Republic)  Slovenia  Swaziland  Sweden  Switzerland  Taiwan  Turkey  United Kingdom", "recall_number": "D-1203-2018", "product_description": "Respitrol, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512.  NDC: 49726-003-02", "product_quantity": "1,869 bottles", "reason_for_recall": "Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia", "recall_initiation_date": "20180823", "center_classification_date": "20180917", "termination_date": "20210127", "report_date": "20180919", "code_info": "Lot: RE/030717E, exp 7/2019"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "69013", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W. Field Court, Suite 300", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1571-2014", "product_description": "Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42", "product_quantity": "5,539 vials", "reason_for_recall": "Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point", "recall_initiation_date": "20140805", "center_classification_date": "20140922", "termination_date": "20150521", "report_date": "20141001", "code_info": "Lot: 12RIF4A, Expiration Date: 9/30/2014"}, {"country": "United States", "city": "Cary", "address_1": "3909 3 Oaks Rd", "reason_for_recall": "Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products", "address_2": "", "product_quantity": "38,792 cases", "code_info": "Product Code: 6512; Lots: 51381, EXP 8/8/2017; 51433, 51453, EXP 8/15/2017; 51931, EXP 9/12/17; 52754 EXP 10/31/2017; 53326, EXP 11/28/2017; 53826, EXP 1/9/2018; 54266, EXP /15/2018; 54606, EXP 3/6/2018; 54872, EXP 3/21/2018; 55310, 55319, EXP 4/17/2018; 55823, EXP 5/22/2018;  56030, EXP 6/5/2018; 56039, EXP 5/30/2018; 56054, EXP 6/5/2018; 56385, 56408, 56417, EXP 6/26/2018; 56424, 56432, 56440, 56450, EXP 7/5/2018; 56828, EXP 7/27/2018; 57436, EXP 8/29/2018; 57860, EXP 9/25/2018; 58010, EXP 10/2/2018; 58126, EXP 10/9/2018; 58753 EXP 11/6/2018; 59089, 59129, 59143, EXP 11/13/2018; 59762, EXP 1/2/2019; 60261, 60308, EXP 1/22/2019; 60957, EXP 3/12/2019; 61411 EXP 4/9/2019; 61715, EXP 4/23/2019.", "center_classification_date": "20180209", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico,  Canada, United Kingdom, Ireland, Netherlands, New Zealand", "state": "IL", "product_description": "Toothette Suction Toothbrush with Perox-A-Mint solution and Mouth Moisturizer. Includes  0.25 fl.oz./7mL Perox-A-Mint solution, 0.07oz/2g Mouth Moisturizer.  Sage Products, Inc., 3909 Three Oaks Road, Cary, IL 60013. NDC: 53462-922-16", "report_date": "20180221", "classification": "Class II", "openfda": {}, "recalling_firm": "Sage Products Inc", "recall_number": "D-0353-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77992", "termination_date": "20181213", "more_code_info": "", "recall_initiation_date": "20170822", "postal_code": "60013-1804", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Temple", "address_1": "5920 S General Bruce Dr", "reason_for_recall": "Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.", "address_2": "Ste 100", "product_quantity": "430 Bags", "code_info": "Lot # 00083844 Exp. 07/13", "center_classification_date": "20140916", "distribution_pattern": "TN, PA, and TX", "state": "TX", "product_description": "NORepinephrine 4 mg in 250 mL Sodium Chloride0.9%, For IV Use Only, Flexible Bag, Rx only, UNIQUE PHARMACEUTICALS, Inc.Temple, TX USA 76502", "report_date": "20140924", "classification": "Class II", "openfda": {}, "recalling_firm": "Unique Pharmaceutical, Ltd", "recall_number": "D-1587-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67904", "termination_date": "20160126", "more_code_info": "", "recall_initiation_date": "20130417", "postal_code": "76502-5803", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Elizabeth", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73474", "recalling_firm": "Actavis Elizabeth LLC", "address_1": "200 Elmora Ave", "address_2": "N/A", "postal_code": "07202-1106", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide", "recall_number": "D-0816-2016", "product_description": "Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets, 5 mg, 100 ct. bottle, Rx Only.  Manufactured by: Actavis Elizabeth LLC, Elmora Avenue, Elizabeth, NJ 07207. Distributed by: Actavis, Inc., 80 Columbia Road, Bldg B, Morristown, NJ 07960. NDC: 45963-743-11.", "product_quantity": "38,507 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for impurities.", "recall_initiation_date": "20160216", "center_classification_date": "20160407", "termination_date": "20170922", "report_date": "20160413", "code_info": "Lot #: 5245M141, Expiry: 6/16; Lot #: 0953C151, Expiry date: 8/16Lot #: 1728D151, Expiry: 9/16; Lot #: 3205G152, Expiry: 3/17.", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbia", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92348", "recalling_firm": "Apollo Care, LLC", "address_1": "3801 Mojave Ct Ste 101", "address_2": "N/A", "postal_code": "65202-4042", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Missouri only", "recall_number": "D-0635-2023", "product_description": "Ketamine Injection, 50 mg per 5 mL (10 mg/mL), Single-Use Syringe, Rx only, Apollo Care, LLC, 3801 Mojave Ct., Suite 101, Columbia, MO 65202. NDC 71170-050-05", "product_quantity": "2040 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230502", "center_classification_date": "20230518", "report_date": "20230524", "code_info": "Lot #: AC-016627, Exp. Date 06/17/2023; AC-016635, Exp. Date 07/08/2023; AC-016662, Exp. Date 09/30/2023"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "1299 vials and syringes", "code_info": "Lot #: a) Medroxyprogesterone 150-30 mL: 20130301-H, Exp 6/1/2013.", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Medroxyprogesterone Acetate Injection, all strengths and all presentations including a) Medroxyprogesterone 150-30 mL, b) Medroxyprogesterone Acetate 150 mg/mL in 1 mL, 10 mL, 30 mL vials, c) Medroxyprogesterone Acetate 150 mg/mL PF syringe, d) Medroxyprogesterone Acetate 150 mg/mL syringe, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-386-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66403", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-66403-011", "product_description": "Ciprofloxacin Tablets, USP, 500 mg,100-count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A, NDC 0378-7098-01", "product_quantity": "941,270 bottles", "reason_for_recall": "CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.", "recall_initiation_date": "20130913", "center_classification_date": "20131104", "termination_date": "20150723", "report_date": "20131113", "code_info": "Lot #: 2002732, 2002733, 2002734, 2002735, 2002736, 2002737, 2002738, 2002739, 2002740, 2002741, 2002742, 2002743, 2002744, 2002745, 3030000, 3030001, 3030002, 3030003, 3030004, 3030005, 3030006, 3030016, 3030017, 3030018, 3030216, 3030217, 3030218, 3030219, 3030220, 3030221, 3030222, 3030223, 3030224, 3030225, 3030226, 3030227, 3030228, 3030229, 3030238, 3030351, 3030352, 3030354, 3030355, 3030356, 3030357, 3030358, 3031790, 3031792, 3031793, 3031794, 3031795, 3031796, 3031797, 3031798, 3032035, 3032036, 3032037, 3032038, 3032039, 3032040, 3032041, 3032042, 3032043, 3032044, 3032045, 3032046"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1424-2020", "product_description": "Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone acetonide 0.01%), a) 0.5 FL OZ (15 mL), b) 2 FL OZ (60 mL) bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600", "product_quantity": "543 units", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "01-17-2020:45@4, 01-13-2020:40@27, BUD 7/7/2020   01-21-2020:43@11, BUD 7/18/2020  01-28-2020:88@15, 01-31-2020:73@6, BUD 7/26/2020  02-12-2020:43@16, 02-17-2020:86@5, BUD 8/10/2020  02-21-2020:23@1, BUD 8/16/2020"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "70148", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-470-2015", "product_description": "Virginia Hospital Center (VA) TPN Neonatal Day 1 Bag, Trophamine 5.5 gm, Dextrose 10%, Additives: Calcium Gluconate 0.46mEq/mL, 600 mg, compound vol: 250 ml, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box, each container is lined with a polystyrene insert; CAPS, Allentown, PA.", "product_quantity": "12 bags", "reason_for_recall": "Non-Sterility: Out of specification results for the sterility test for microbial contamination.", "recall_initiation_date": "20141217", "center_classification_date": "20150408", "termination_date": "20150819", "report_date": "20150415", "code_info": "lot number 37-74714, Made on 15 DEC 2014, EXP 24 DEC 2014, CAPS Rx: 37-74714-0-12-R, Disp ID: 37-1124493"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6730"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["198440"], "spl_id": ["17f3b749-01e8-2561-e063-6294a90a5d3b"], "spl_set_id": ["76cb8209-6c43-322e-e053-2991aa0a51eb"], "package_ndc": ["0904-6730-60", "0904-6730-80", "0904-6730-59", "0904-6730-61"], "is_original_packager": [true], "upc": ["0309046730804", "309046730606", "309046730804"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "84857", "recalling_firm": "Contract Pharmacal Corporation", "address_1": "135 Adams Ave", "address_2": "", "postal_code": "11788-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0858-2020", "product_description": "Major Extra Strength Acetaminophen Tablets, 500 mg Pain Reliever/Fever Reducer, packaged in a) 100-count bottles (NDC 0904-6730-60; UPC 3 09046 73060 6) and b) 1000-count bottles (NDC 0904-6730-80; UPC 3 09046 73080 4) Distributed by Major Pharmaceuticals 17177 N. Laurel Park Drive, Suite 233 Livonia, MI 45162 USA", "product_quantity": "a) 1176 bottles b) 6,216 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.", "recall_initiation_date": "20200203", "center_classification_date": "20200227", "termination_date": "20240422", "report_date": "20200219", "code_info": "Lot #: 193005, Exp. Date 08/21", "more_code_info": ""}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1102-2016", "product_description": "All triamcinolone Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65008", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-500-2013", "product_description": "Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for:  Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.  Made in India", "product_quantity": "3,048 bottles", "reason_for_recall": "Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..", "recall_initiation_date": "20130422", "center_classification_date": "20130530", "termination_date": "20140414", "report_date": "20130605", "code_info": "Lot # ZRMB11004, Exp 09/13"}, {"status": "Terminated", "city": "Star", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64619", "recalling_firm": "Palmer Natural Products", "address_1": "11665 W State St", "address_2": "N/A", "postal_code": "83669-5223", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Florida, Idaho, California and Hong Kong.  This product can be ordered on line.", "recall_number": "D-232-2013", "product_description": "Aniracetam and Choline, Aniracetam 460 mg, Choline 76 mg, 180 capsules per bottler, non-Rx, distributed by BoostYourGrade, BoostYourGrade, LLC  Orlando, FL", "product_quantity": "250 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: The products are unapproved drugs", "recall_initiation_date": "20130311", "center_classification_date": "20130401", "termination_date": "20130807", "report_date": "20130410", "code_info": "All lot codes."}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "1", "code_info": "C5115 Exp 9/11/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Atropine Sulfate 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-702-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65445", "recalling_firm": "West-Ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-824-2013", "product_description": "West-ward Belladonna Alkaloids with Phenobarbital Tablets, a) 1000-count bottle (NDC 0143-1140-10), b) 5000-count bottle (NDC 0143-1140-51), Rx only, Manufactured by West-ward Pharmaceutical Corp., Eatontown, N.J., 07724", "product_quantity": "14,503 bottles", "reason_for_recall": "Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.", "recall_initiation_date": "20130516", "center_classification_date": "20130725", "termination_date": "20140623", "report_date": "20130731", "code_info": "Lot # 69098A, 69098B, 69100A; Exp 8/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77687", "recalling_firm": "Hospira Inc., A Pfizer Company", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0980-2017", "product_description": "Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 5 mL Single-use vial, Rx Only, Sterile, Manufactured by: Gland Pharma Limited, Hyderabad, India,  Manufactured for:  Hospira, Inc, Lake Forest, IL 60045 ---  NDC  0409-1140-01", "product_quantity": "701 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point", "recall_initiation_date": "20170706", "center_classification_date": "20170714", "termination_date": "20190910", "report_date": "20170726", "code_info": "Lot:  DP601, exp 10/2018"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0753-2019", "product_description": "Dr. King's SafeCare Rx Adrenal Burnout Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955097921, NDC 57955-0981-2", "product_quantity": "1491 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021616C Exp. 02/19; 0711116P Exp. 07/19; 102816J Exp. 10/19; 030117N Exp. 03/20"}, {"status": "Terminated", "city": "Gaithersburg", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81218", "recalling_firm": "Sprayology", "address_1": "18914 Bonanza Way", "address_2": "N/A", "postal_code": "20879-1512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0126-2019", "product_description": "Diet Power, Homeopathic Oral Spray 1.38 fl. oz. (41 mL). Manufactured by Sprayology Gaithersburg, MD 20879. NDC 61096-0004-1", "product_quantity": "3634 bottles", "reason_for_recall": "CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.", "recall_initiation_date": "20181009", "center_classification_date": "20181030", "termination_date": "20190418", "report_date": "20181107", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA017514"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-6138", "0990-7138", "0990-7972"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["IRRIGATION"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["486515"], "spl_id": ["ea49c260-0be5-48b8-9e97-bef5a4ca584e"], "spl_set_id": ["3cfdeee0-ff14-4341-8396-b11c2a037c60"], "package_ndc": ["0990-7138-09", "0990-7138-36", "0990-6138-22", "0990-6138-03", "0990-7972-05", "0990-7972-07"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "87484", "recalling_firm": "ICU Medical Inc", "address_1": "600 N Field Dr", "address_2": "N/A", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA to include Puerto Rico", "recall_number": "D-0313-2021", "product_description": "0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manufactured for ICU Medical, Inc., Lake Forest, Illinois, 60045 USA. NDC 0990-7138-09", "product_quantity": "425,628 bottles", "reason_for_recall": "Presence of particulate matter.one confirmed  customer report of particulate matter within two semi-rigid bottles identified prior to use", "recall_initiation_date": "20210309", "center_classification_date": "20210325", "termination_date": "20220928", "report_date": "20210331", "code_info": "Lots: 16-808-4B, 16-803-4B, 16-809-4B, Exp. April 01, 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1711-2019", "product_description": "TRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0151-50", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "70 ml", "code_info": "All lots distributed between November 2014 and May 2015;    02112015@39, 8/10/2015; 02032015@99, 8/2/2015; 04012015@25, 9/28/2015;   04272015@55, 10/24/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix AT-6  (60 mg/4 mg/0.3 mg) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1789-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "529 units", "code_info": "Rx #'s: 0358246, 0364805,  0368284,  0378756,  0380820,  0387648,  0388175,  0388294,  0388761,  0391370,  0393218,  0393296,  0394349,  0394946,  0395082,  0395861,  0396187,  0398267,  0401319,  0404291,  0405612,  0388186,  0399034,  0386335,  0400431,  0407531,  0358246,  0378756,  0388743,  0400047,  0404363,  0388082,  0409372,  0348455,  0350663,  0353518,  0355129,  0355693,  0356375,  0357470,  0357616,  0358082,  0358244,  0358434,  0359158,  0363285,  0365259,  0367960,  0369601,  0370844,  0370856,  0371600,  0372364,  0373144,  0373375,  0373510,  0374111,  0374998,  0375459,  0375602,  0376024,  0376332,  0376872,  0377260,  0377875,  0377985,  0379138,  0379565,  0381219,  0383350,  0383828,  0383945,  0385030,  0386074,  0386125,  0386686,  0386742,  0387013,  0387677,  0387846,  0387958,  0388044,  0388436,  0388779,  0388809,  0389393,  0389418,  0389598,  0390069,  0390100,  0390105,  0390505,  0390514,  0390727,  0390999,  0391218,  0391382,  0391595,  0391844,  0391948,  0391988,  0392128,  0392227,  0392536,  0392693,  0392724,  0393539,  0393726,  0393837,  0393890,  0394052,  0394339,  0394442,  0394610,  0394740,  0394779,  0394933,  0395044,  0395610,  0396031,  0396423,  0396428,  0396488,  0396514,  0396850,  0396858,  0396885,  0397148,  0397215,  0397247,  0397393,  0397721,  0397747,  0398357,  0398790,  0398832, 0399045,  0399061,  0399186,  0399368,  0399512,  0399565,  0399867,  0400110,  0400648,  0400692,  0401141,  0401171,  0401436,  0401685,  0401963,  0402524,  0402833,  0402836,  0403131,  0403599,  0403651,  0403776, 0404125, 0404206,0404594,0405337, 0405746, 0406186, 0406350, 0406503, 0406533, 0406608, 0406961, 0407011, 0407522, 0407608, 0408149, 0408243, 0408471, 0408475, 0408733, 0408803, 0408948, 0409227, 0409652, 0408211, 0370597, 0372090, 0372291, 0377260, 0383350, 0384600, 0386742, 0387759, 0394740, 0395554, 0398507, 0399696, 0400665, 0407851, 0384600, 0390561, 0390730, 0391280, 0404039, 0398586, 0387759, 0363140, 0373946, 0379198, 0381414, 0388131, 0390621, 0391087, 0396493, 0402322, 0406179, 0406683, 0407311, 0407850, 0408048, 0392605, 0378371, 0388907, 0391868, 0390192, 0396500, 0352172, 0357035, 0358183, 0358360, 0360788, 0366242, 0366923, 0368523, 0369902, 0374538, 0375333, 0375959, 0377935, 0378040, 0378351, 0379207, 0381237, 0382171, 0385235, 0386937, 0387960, 0388158, 0388210, 0388404, 0388444, 0388445, 0388596, 0388605, 0389108, 0389341, 0389709, 0390347, 0390351, 0390846, 0391197, 0391199, 0391635, 0391700, 0391753, 0392003, 0392022, 0392047, 0392213, 0392423, 0392641, 0392690, 0393922, 0394131, 0394193, 0394388, 0394635, 0394718, 0394798, 0395372, 0395626, 0395876, 0396249, 0396718, 0397811, 0398107, 0398194, 0398343, 0398844, 0398887, 0398982, 0399110, 0399320, 0399528, 0399765, 0400046, 0400096, 0400297, 0400421, 0400424, 0400598, 0400913, 0401400, 0401500, 0401680, 0401934, 0402088, 0402325, 0402328, 0402586, 0402967, 0403274, 0403345, 0403607, 0404401, 0405474,0405498, 0405724, 0406291, 0406457, 0406542, 0407511, 0408231, 0409030, 0409062, 0409526, 0409607, 0409759, 0410307, 0393753, 0397762, 0403540, 0374221, 0382214, 0395621, 0397852, 0402288, 0406445, 0399687, 0374221, 0366701, 0351976, 0354103, 0384453, 0390423, 0391629, 0393615, 0396582, 0397827, 0398720, 0399013, 0403466, 0406583, 0409862, 0397208, 0361392, 0379145, 0380920, 0387005, 0400616, 0404590, 0404931, 0396725, 0392873, 0357803, 0363807, 0365784, 0370228, 0372609, 0376996, 0377620, 0378319, 0380457, 0381999, 0382394, 0382527, 0382743, 0382990, 0386135, 0386929, 0387451, 0387674, 0389081, 0389143, 0389875, 0390000, 0390409, 0391030, 0391711, 0392245, 0392563, 0392705, 0392767, 0393396, 0393794, 0394466, 0395061, 0396510, 0397503, 0397715, 0397737, 0397916, 0397953, 0398923, 0399635, 0399757, 0399812, 0400282, 0400880, 0402467, 0403426, 0403519, 0403728, 0403832, 0404015, 0404522, 0405565, 0405585, 0406128, 0406628, 0407265, 0407357, 0407736, 0407839, 0408178, 0408378, 0409610, 0409944, 0388717, 0394665, 0367237, 0368886, 0401105, 0395886, 0397863, 0388295, 0387427, 0388295, 0397030", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ALPROSTADIL  10MCG/ML INJECTABLE 10 ML, 20 ML, 3 ML, 30 ML, 5 ML, 6 ML; ALPROSTADIL  15MCG/ML INJECTABLE 5 ML; ALPROSTADIL  20MCG/ML INJECTABLE 10 ML, 10 MLS, 20 ML, 3 ML, 30 ML, 4 ML, 40 ML, 5 ML, 6 ML; ALPROSTADIL  24MCG/ML INJECTABLE 6 ML; ALPROSTADIL  25MCG/ML INJECTABLE 10 ML; ALPROSTADIL  30MCG/ML INJECTABLE 10 ML; ALPROSTADIL  35MCG/ML INJECTABLE 10 ML; ALPROSTADIL  40MCG/ML INJECTABLE 10 ML, 10 ML, 10 VIAL, 15 ML, 2 ML, 20 ML, 3 ML, 30 ML, 40 ML, 5 ML, 50 ML, 6 ML; ALPROSTADIL  50MCG/ML INJECTABLE\t10 ML, 2 ML, 20 ML, 5 ML; ALPROSTADIL  60MCG/ML INJECTABLE\t20 ML; ALPROSTADIL (M) 500MCG/ML INJECTABLE 10 ML; ALPROSTADIL 100MCG/ML INJECTABLE 5 ML; ALPROSTADIL, STERILE 1,000MCG/ML GEL 10 ML, 12 ML, 20 ML, 3 ML, 30 ML, 6 ML; ALPROSTADIL/PAPAVERINE  10MCG/9MG/ML INJECTABLE; ALPROSTADIL/PHENT 10MCG/0.5MG/ML INJECTABLE 10 ML, 5 ML; ALPROSTADIL/PHENT 17MCG/0.5MG/ML INJECTABLE 10 ML; ALPROSTADIL/PHENTOLAMINE 40MCG/2MG/ML INJECTABLE 10 ML (50 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1452-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1819-2019", "product_description": "FERRIC CARBOXYMALTOSE 750mg/50ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Pennington", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69911", "recalling_firm": "Zydus Pharmaceuticals USA Inc", "address_1": "73 Route 31 N", "address_2": "N/A", "postal_code": "08534-3601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0299-2015", "product_description": "Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534;  NDC 68382-248-01, UPC 3 68382 24801 5.", "product_quantity": "58,920 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.", "recall_initiation_date": "20141126", "center_classification_date": "20141216", "termination_date": "20170925", "report_date": "20141224", "code_info": "Lot #: MP2137, MP2138, MP2139, Exp 01/16; MP3614, Exp 03/16; MP5611, MP5613, Exp 05/16"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82941", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1336-2019", "product_description": "Testosterone 200 mg/mL, 30 mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846, NDC 69699-1702-30", "product_quantity": "704 vials", "reason_for_recall": "Lack of Sterility Assurance.", "recall_initiation_date": "20190523", "center_classification_date": "20190607", "termination_date": "20210205", "report_date": "20190619", "code_info": "Lot #: 10242018:70/B Exp. 08/31/2019; 10302018:63/A Exp. 08/31/2019"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-655-2013", "product_description": "Methylcobalamin 12.5 mg/ml, Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "95ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABCBJBA:55, Exp date: 4/17/2013; Exp date: Lot number CABDCCAB:52, Exp date: 7/21/2013 and Lot number CABDCGAC:50, Exp date: 8/25/2013."}, {"status": "Terminated", "city": "Clive", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "68626", "recalling_firm": "Medical Supply Liquidators Llc", "address_1": "10500 Hickman Rd Ste F", "address_2": "N/A", "postal_code": "50325-3706", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.", "recall_number": "D-1531-2014", "product_description": "G.A.C. 375 Injection USP, packaged in 30 ml vials, Sterile, For IM or Deep SQ Use, Multiple Dose Vial, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.", "product_quantity": "N/A", "reason_for_recall": "Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer", "recall_initiation_date": "20140625", "center_classification_date": "20140806", "termination_date": "20170314", "report_date": "20140813", "code_info": "All lot numbers and exp dates"}, {"status": "Terminated", "city": "Toronto", "state": "N/A", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71418", "recalling_firm": "Apotex Inc.", "address_1": "150 Signet Drive", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Hawaii and Puerto Rico", "recall_number": "D-1215-2015", "product_description": "Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1", "product_quantity": "4,584 bottles", "reason_for_recall": "Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.", "recall_initiation_date": "20150529", "center_classification_date": "20150707", "termination_date": "20170303", "report_date": "20150715", "code_info": "Lot #: KP4529,  Exp 10/2015"}, {"status": "Terminated", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204216"], "brand_name": ["KETOROLAC TROMETHAMINE"], "generic_name": ["KETOROLAC TROMETHAMINE"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-700", "25021-701"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["KETOROLAC TROMETHAMINE"], "rxcui": ["860092", "1665459", "1665461"], "spl_id": ["ff55e1ab-2a8d-4a56-8b72-5e0a8e00d866"], "spl_set_id": ["62591551-a644-4b2c-a0de-982e906fabc3"], "package_ndc": ["25021-700-01", "25021-701-01", "25021-701-02"], "is_original_packager": [true], "unii": ["4EVE5946BQ"]}, "product_type": "Drugs", "event_id": "82741", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 700", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1274-2019", "product_description": "Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL  Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC:  25021-701-02", "product_quantity": "75,825 vials", "reason_for_recall": "Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.", "recall_initiation_date": "20190430", "center_classification_date": "20190509", "termination_date": "20200928", "report_date": "20190515", "code_info": "Lot #: M813513, Exp. Feb 2020"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "434 units", "code_info": "Rx #'s:   0367755          0397544    0397544      0394203    0394203    0353087    0394203        0394203      0391064    0396617    0396618    0397379    0397665    0389435    0397604    0398197    0400182      0406428    0406441    0407299    0408671    0392392    0392866    0395109          0397604      0398121    0406401    0406428    0391064    0392866    0391064    0392394    0397379      0397401    0396330    0409785    0392392    0409993    0389435    0392394    0394007    0398254      0398371    0398197    0397564    0392532    0397401    0406158    0408033    0388839    0398070    0390935    0391064    0392392        0400496    0392394    0391064      0401695    0394973      0409350    0389048      0392392    0395192    0395322    0396495    0397014    0397235    0397286    0398200    0410339    0408395    0392392    0396495    0402468    0405322    0400938      0398892    0404270    0391064    0403246    0407249    0406513    0406511    0388935    0398116    0398651    0400184    0404681    0396015    0406879    0408191    0407760    0398152    0392177      0396015    0396776        0397935    0398690    0388570    0404681    0396331    0386589    0392123    0400499    0406879    0397574    0387654      0387657      0392123    0389739    0392177    0388570      0389520    0405648    0395417    0408169    0388570    0386589    0398344    0398897    0399058    0404400    0406370    0406409    0387654    0387657    0388315        0395460    0397237    0398140    0401098      0388570      0392120    0405324    0405865    0398386    0396384    0398522    0407403    0395328    0407403    0401899    0395328    0396384          0400983    0385425    0385425          0408240    0398953    0398955    0399006    0397926        0397701      0398953    0406581        0397701    0398955    0397926                                                                      0403958    0395327    0399741    0399741    0398231    0398955    0395209    0395209        0395209    0398953    0398955    0408343    0408356    0408359    0408361    0398953              0398955      0399741    0398953    0395327    0403237    0398228    0403237    0403822    0403955    0403237    0404870    0352507    0354115        0355699    0357889    0359365      0360370    0364979    0369341      0371280    0372079    0373472    0374032    0374306    0376181            0378274    0380074    0381850    0385344    0385547    0386110      0386788      0387127    0387422    0387464    0387859    0388713    0389087    0389291    0389369    0392010    0392179    0393703      0393791    0394288      0395465    0395688      0396321    0397535    0399096    0400643      0400805    0400842      0400849    0401048    0401101        0401253    0402339    0403298      0405184    0405477    0405647    0406833    0406870    0409282    0403815    0384363    0398902    0354644    0359373    0359556      0361151    0365492        0374306    0384183    0385520    0385547    0387466      0389030    0389369    0389936      0390088        0390875    0391203        0391252    0391254    0391255    0391808    0392555    0395499    0396125    0397244      0401048    0401553    0402814    0403285    0404205    0404211    0404219    0406766    0358069    0401639    0363813    0386485      0387583    0390418      0390538      0391203    0393542    0394622    0401048    0408256    0348902    0363945    0365492    0366731    0382057    0392179      0396006    0399798      0407366    0365954    0404604    0354990    0363945      0385338      0395499    0400889    0379753          0389066    0393699      0365954    0391256    0380645      0353540    0395979      0409426", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies", "state": "FL", "product_description": "LIDOCAINE HCL  (STERILE) 4% JELLY\t120 ML  \t  \t  \t  \t  \t30 ML;  \t  LIDOCAINE HCL  4% SOLUTION\t200 ML  \t300 ML  \t500 ML  \t  \t  \t  \t600 ML;  \t  LIDOCAINE HCL 1% INJECTABLE\t100 ML  \t  \t  \t  \t  \t1000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t1200 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1250 ML  \t  \t150 ML  \t  \t  \t  \t  \t1500 ML  \t  \t180 ML  \t  \t20 ML  \t200 ML  \t  \t  \t  \t  \t2000 ML  \t240 ML  \t250 ML  \t  \t  \t  \t2500 ML  \t  \t300 ML  \t  \t  \t  \t  \t  \t350 ML  \t360 ML  \t  \t400 ML  \t480 ML  \t  \t50 ML  \t500 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t60 ML  \t600 ML  \t  \t  \t  \t720 ML  \t  \t750 ML  \t7500 ML  \t90 ML;  LIDOCAINE HCL 10% INJECTABLE\t1000 ML;  LIDOCAINE HCL IN BSS - P.F. OPHTHALMIC 1% INJECTABLE\t30 ML;  LIDOCAINE HCL W/EPI (25X30ML) MDV *** 1%-1:100000 INJECTABLE\t150 MLS  \t180 MLS  \t50 VIALS;  LIDOCAINE HCL, AQUEOUS  2% INJECTABLE\t100 ML  \t  \t  \t  \t1000 ML  \t  \t  \t120 ML  \t1200 GM  \t1200 ML  \t  \t  \t  \t  \t  \t  \t  \t150 ML  \t  \t1500 ML  \t20 ML  \t200 ML  \t  \t2000 ML  \t240 ML  \t250 ML  \t  \t  \t  \t  \t2500 ML  \t  \t300 ML  \t  \t  \t  \t40 ML  \t  \t450 ML  \t480 ML  \t  \t50 ML  \t  \t  \t  \t  \t500 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t600 ML  \t  \t  \t  \t  \t80 ML;  LIDOCAINE HCL, AQUEOUS PF 2% INJECTABLE\t1200 ML  \t1500 ML  \t1600 ML  \t200 ML  \t250 ML  \t50 ML  \t500 ML  \t600 ML  \t  \t  \t  \t900 ML;  LIDOCAINE HCL, AQUEOUS, BUFFERED, P.F. 2% INJECTABLE\t1000 ML  \t500 ML;  \t  \t  \t  LIDOCAINE HCL, P.F. 0.5% INJECTABLE\t1000 ML;  LIDOCAINE HCL, P.F. 1% INJECTABLE\t100 ML  \t  \t  \t12 ML  \t  \t  \t120 ML  \t  \t  \t  \t  \t  \t125 ML  \t150 ML  \t24 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t240 ML  \t2500 ML  \t2670 ML  \t30 ML  \t300 ML  \t  \t40 ML  \t48 ML  \t  \t  \t50 ML  \t  \t  \t6 ML  \t  \t  \t  \t60 ML  \t  \t  \t  \t  \t  \t  \t  \t720 ML  \t80 ML  \t900 ML;  LIDOCAINE HCL, P.F. 4% INJECTABLE\t100 ML  \t1000 ML  \t125 ML  \t225 ML  \t240 ML  \t75 ML  LIDOCAINE HCL/METHYLCELLULOSE 1%/2% JELLY\t2 ML;  LIDOCAINE HCL/METHYLCELLULOSE 2%/2% JELLY\t1000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t1000 MLS  \t12000 ML  \t200 ML  \t2000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2000 MLS  \t  \t3000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4000 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t500 ML  \t  \t5000 ML  \t  \t  \t  \t  \t  \t  \t6000 ML  \t  \t  \t  \t  \t  \t  \t750 ML;  LIDOCAINE HCL/METHYLCELLULOSE 4%/2% JELLY\t1000 ML;  LIDOCAINE HCL/METHYLCELLULOSE 5%/2% JELLY\t1000 ML;  \t  LIDOCAINE HCL/METHYLCELLULOSE 8%/2% JELLY\t1000 ML  (111 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1558-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62443", "termination_date": "20140815", "more_code_info": "", "recall_initiation_date": "20120521", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0750-2023", "product_description": "MSA 7.84% MSG 8.56% (0.92M) Comp. Sol. 1000 ml bag, Rx only, Central Admixture Pharmacy Services, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-8029-1, code 7128580291.", "product_quantity": "653 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-882955, Exp 04/29/2023; 37-884753, 37-884755, Exp 05/06/2023; 37-887536, 37-887537, Exp 05/17/2023; 37-888532, Exp 05/23/2023; 37-892474, Exp 06/07/2023; 37-896761, Exp 06/23/2023; 37-897261, Exp 06/27/2023"}, {"status": "Terminated", "city": "Littleton", "state": "NH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66198", "recalling_firm": "Northern New England Compounding Pharmacy LLC", "address_1": "262 Cottage St Ste 116", "address_2": "N/A", "postal_code": "03561-4143", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "CT", "recall_number": "D-1060-2013", "product_description": "Hydroxocobalamin MDV 5 mg/mL (5,000 mcg/mL) Inj., 10 mL vial X 3, Eastern States Compounding Pharmacy, Littleton, NH 03561", "product_quantity": "1 Vial", "reason_for_recall": "Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured.", "recall_initiation_date": "20130905", "center_classification_date": "20130917", "termination_date": "20130917", "report_date": "20130925", "code_info": "Lot #: 08022013@34, Exp11/3/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Deer Park", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "65842", "recalling_firm": "Healthy Life Chemistry Inc dba Purity First", "address_1": "13A Lucon Dr", "address_2": "N/A", "postal_code": "11729-5711", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Approximately 30% of all finished products were sold to customers in interstate to include but may not be limited to NY, NJ & CT via UPS.  Products are promoted and sold directly to customers at Healthy Life Chemistry's retail store at 13A Lucon Drive in Deer Park, NY, on the company website (www.purityfirst.com), and are available at the health food store, Total Health, located at 120 Rte 110, Farmingdale, NY (www.totaldiscountvitamins.com).", "recall_number": "D-373-2014", "product_description": "B-50 capsules, 100-count bottles, labeled in part as Healthy Life Chemistry, By Purity First, Manufactured for: Purity First Health Products, Inc. Healthy Life Chemistry 51 Florida Street, Farmingdale, NY 11735; 1-800-696-7017", "product_quantity": "unknown", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis of this product found it to contain undeclared steroids and steroid-like substances making this an unapproved new drug.", "recall_initiation_date": "20130731", "center_classification_date": "20131218", "termination_date": "20150511", "report_date": "20131225", "code_info": "lot numbers: F03Q, C02R"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "90191", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0880-2022", "product_description": "Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blisters per card, 10 cards per carton, Unit Dose NDC 68084-446-11, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217,  NDC: 68084-446-01", "product_quantity": "1603 cartons", "reason_for_recall": "Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.", "recall_initiation_date": "20220503", "center_classification_date": "20220518", "termination_date": "20230928", "report_date": "20220525", "code_info": "Lot # 1003829, Exp date 1/31/23", "more_code_info": ""}, {"status": "Ongoing", "city": "Nicholasville", "state": "KY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89909", "recalling_firm": "TMC Acquisition LLC dba Tailor Made Compounding", "address_1": "200 Moore Dr", "address_2": "", "postal_code": "40356-8512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1201-2022", "product_description": "Estradiol Cypionate 10mg/mL, a) 1mL-vial, b) 2 mL-vial, Room Temperature, Tailor Made Compounding", "product_quantity": "349 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220307", "center_classification_date": "20220714", "report_date": "20220720", "code_info": "Batch #: a) 01052210A1, Exp 4/5/2022; 10202101A1, Exp 4/18/2022; 01052210A1 7/4/2022; b)10202102A1, Exp 4/18/2022; 12022126A1, Exp 5/31/2022; 01052210A1, Exp 7/4/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0526-2018", "product_description": "Testosterone Cypionate USP (Micronized)  for prescription compounding, packaged in a)100g (NDC 58597-0078-6); b) 500g (NDC 58597-0078-7); c) 1000g (NDC 58597-0078-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "611400 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 032117A-6, Exp. 01/21/2019; 112916-2, 112916-4, Exp. 10/17/2018;   b) 032117A-4, 032117A-5, Exp. 01/21/2019; 112916-1, Exp. 10/17/2018; 112916-4, Exp. 10/17/2018; c) 032117A-1, 032117A-2, 032117A-3, 032117A-4, 032117A-5, Exp. 01/21/2019; 112916-1, 112916-2,  112916-3, 112916-4, Exp. 10/17/2018."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: TRI-BUFFERED ASPIRIN, Tablet, 325 mg may have potentially been mislabeled as the following drug:  ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg, NDC 44183044001, Pedigree: W003596, EXP: 5/31/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "TRI-BUFFERED ASPIRIN, Tablet, 325 mg has the following codes:   Pedigree: W003581, EXP: 6/24/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "TRI-BUFFERED ASPIRIN, Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904201559.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1026-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA018016"], "brand_name": ["SODIUM CHLORIDE"], "generic_name": ["SODIUM CHLORIDE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0043", "0338-0049"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM CHLORIDE"], "rxcui": ["1807551", "1807552", "1807627", "1807630", "1807631", "1807632", "1807633", "1807634", "1807639"], "spl_id": ["6ab23768-efd2-4ff1-b336-0dda08dc56e1"], "spl_set_id": ["f55bd888-5e01-474d-871b-24654c070178"], "package_ndc": ["0338-0049-01", "0338-0049-02", "0338-0049-03", "0338-0049-04", "0338-0049-10", "0338-0049-41", "0338-0049-11", "0338-0049-31", "0338-0049-48", "0338-0049-18", "0338-0049-38", "0338-0043-03", "0338-0043-04"], "is_original_packager": [true], "unii": ["451W47IQ8X"]}, "product_type": "Drugs", "event_id": "72816", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0957-2016", "product_description": "0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container Bag, Rx Only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-0049-02", "product_quantity": "255,852 VIAFLEX Plastic Containers", "reason_for_recall": "Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.", "recall_initiation_date": "20151215", "center_classification_date": "20160606", "termination_date": "20220415", "report_date": "20160615", "code_info": "Lot # C980227; Exp. 11/16"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207687"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-044", "16729-045", "16729-046", "16729-047"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["40828d2e-69eb-5d38-e063-6394a90abd70"], "spl_set_id": ["4e06b20d-cc5d-46eb-991b-5972248de3af"], "package_ndc": ["16729-045-10", "16729-045-15", "16729-045-01", "16729-045-16", "16729-045-17", "16729-044-10", "16729-044-15", "16729-044-01", "16729-044-16", "16729-044-17", "16729-046-10", "16729-046-15", "16729-046-01", "16729-046-16", "16729-046-17", "16729-047-10", "16729-047-15", "16729-047-01", "16729-047-16", "16729-047-17"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"], "upc": ["316729047159", "316729047166"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0374-2023", "product_description": "Atorvastatin Calcium Tablets USP 80 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-047-15 UPC 3 16729 04715 9; b) 500 Tablets NDC 16729-047-16 UPC 3 16729 04716 6; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA", "product_quantity": "72,376 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: a)R2100283, R2100288, R2100289, Exp. Date 2/28/2023; R2200235, Exp. Date 1/31/2024; R2201037, R2200952, Exp. Date 6/30/2024; b) R2100291, R2100281, R2100282, R2100292, R2100293, R2100294, R2100290, R2100306, R2100348, R2100349, R2100347, R2100350, R2100356, R2100355, Exp. Date 2/28/2023; R2100461, R2100463, R2100464, Exp. Date 3/31/2023; R2101214, R2101215, R2101216, Exp. Date 9/30/2023; R2101572, R2101573, R2101577, R2101578, R2101585, R2101579, R2101584, R2101587, R2101597, Exp. Date 11/30/2023; R2200801, Exp. Date 6/30/2024;", "more_code_info": ""}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0321-2017", "product_description": "Ultra Amino Blend (Arginine HCL 105 mg + Lysine (L) HCL 150 mg + Ornithine (L) HCL 75 mg + Glutamine (L) 75 mg/ml + Lidocaine HCL 10 mg/mL), (30 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "79 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 06302016A (12/27/2016), 06152016F (12/12/2016), 08152016D (02/11/2017)."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-777-2015", "product_description": "Melphalan active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "132 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0030-2016", "product_description": "Leader Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets per box, Distributed by Cardinal Health, Dublin, OH  43017, NDC 37205-745-65, UPC 0 9629512322 7", "product_quantity": "9,624 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:  2617891, Exp 5/31/2016; 2625092, Exp 6/30/2016"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0864-2023", "product_description": "Tropicamide Ophthalmic Solution, USP 0.1%, 15 mL bottles, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0369-2020", "product_description": "Equate Support Advanced Twin Pack  W-M item #: 567371433, Package Size: 2 x 15 mL, Distributed by: Wal-Mart Stores Inc., Bentonville, AR 72716, NDC 49035-885-49", "product_quantity": "259104 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 19137     05/22            19022     01/22"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0092-2020", "product_description": "Quadmix # 19 (Prostaglandin E1-0.75 mg / Papaverine HCl-150 mg / Phentolamine Mesylate-15 mg / Atropine Sulfate Monohydrate-1.5 mg/vial), Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678383", "product_quantity": "95 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040560"], "brand_name": ["THEOPHYLLINE"], "generic_name": ["THEOPHYLLINE"], "manufacturer_name": ["Nostrum Laboratories, Inc."], "product_ndc": ["29033-001", "29033-002"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["THEOPHYLLINE ANHYDROUS"], "rxcui": ["313291", "348472"], "spl_id": ["cc6d208a-826c-4aae-a78e-da1a91c60699"], "spl_set_id": ["038c2b07-8028-4dc4-847c-adafe1b0e81a"], "package_ndc": ["29033-001-01", "29033-002-01"], "is_original_packager": [true], "upc": ["0329033002011", "0329033001014"], "nui": ["N0000175790", "M0023046"], "pharm_class_epc": ["Methylxanthine [EPC]"], "pharm_class_cs": ["Xanthines [CS]"], "unii": ["0I55128JYK"]}, "product_type": "Drugs", "event_id": "85235", "recalling_firm": "Nostrum Laboratories Inc", "address_1": "1800 N Topping Ave", "address_2": "N/A", "postal_code": "64120-1228", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "TN, MO", "recall_number": "D-1059-2020", "product_description": "Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.", "product_quantity": "4722 bottles", "reason_for_recall": "CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.", "recall_initiation_date": "20200306", "center_classification_date": "20200325", "termination_date": "20220401", "report_date": "20200401", "code_info": "Lot: THE190501, Exp 11/2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: DRONEDARONE HCL, Tablet, 400 mg may be potentially as the following drug:  METHYLERGONOVINE MALEATE, Tablet, 0.2 mg, NDC 43386014028, Pedigree: AD52778_40, EXP: 5/20/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "DRONEDARONE HCL, Tablet, 400 mg has the following codes:   Pedigree: AD52778_52, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "DRONEDARONE HCL, Tablet, 400 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00024414260.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-782-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: NABUMETONE, Tablet, 500 mg may have potentially been mislabeled as the following drug:  guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD46429_1, EXP: 5/15/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "NABUMETONE, Tablet, 500 mg has the following codes:   Pedigree: AD46426_4, EXP: 5/15/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "NABUMETONE, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00185014501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-880-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0666-2020", "product_description": "BAC 160MCG/HYDROM 16MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@20 Exp. 12/20/2019", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: ACETAMINOPHEN, CHEW Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: AD49423_1, EXP: 5/16/2014;  ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003101, EXP: 6/13/2014;  OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD30028_1, EXP: 5/8/2014;  TACROLIMUS,", "address_2": "", "product_quantity": "120 CHEW Tablets", "code_info": "ACETAMINOPHEN, CHEW Tablet, 80 mg has the following codes:   Pedigree: AD49399_1, EXP: 5/16/2014;  Pedigree: W003113, EXP: 6/13/2014;  Pedigree: AD30180_7, EXP: 5/8/2014;  Pedigree: W003050, EXP: 6/12/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ACETAMINOPHEN, CHEW Tablet, 80 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536323307.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-926-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0958-2019", "product_description": "NET Remedies #9 ER 911 Homeopathic Preparation, Oral Liquid, 57 mL, NDC 57955-4209-2", "product_quantity": "20098 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: NR-071118A Exp. 07/20; NR-071218A Exp. 07/20; NR-071218C Exp. 07/20; NR-081017M Exp. 08/19; NR-110117H Exp. 11/19; NR-020118K Exp. 02/20; NR-111517C Exp. 11/19; NR-120317J Exp. 12/19"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PHENYTOIN SODIUM ER, Capsule, 30 mg may have potentially been mislabeled as the following drug:  LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: W003327, EXP: 6/19/2014.", "address_2": "", "product_quantity": "", "code_info": "PHENYTOIN SODIUM ER, Capsule, 30 mg has the following codes:   Pedigree: W003331, EXP: 6/19/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PHENYTOIN SODIUM ER, Capsule, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071374066.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-807-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Dextrose 50% Inj Sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0427-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0627-2023", "product_description": "Piperacillin and Tazobactam for Injection, USP, 3.375 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-217-41", "product_quantity": "223,590 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0100-2020", "product_description": "Sermorelin, 3 mg / GHRP-2, 3 mg / Vial, For SC Use-Lyophilized, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321674092", "product_quantity": "120 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0476-2018", "product_description": "Baclofen USP (Micronized) for prescription compounding, packaged in a) 25g (NDC 58597-8004-4); b)100g (NDC 58597-8004-6); c) 500g (NDC 58597-8004-7); d) 1000g (NDC 58597-8004-8), RX only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.", "product_quantity": "55500 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a) 021816-2, 021816-3, Exp. 08/24/2018; 70616-1, Exp. 01/31/2019; b) 021816-1, Exp. 08/24/2018; 070616-1, Exp. 01/31/2019; c) 021816-1, Exp. 08/24/2018;  070616-1, Exp. 01/31/2019; d) 021816-1, Exp. 08/24/2018;  070616-1, exp. 01/31/2019."}]